Groupe Bruxelles Lambert (ENXTBR:GBLB) Valuation After Q1 2026 Sales Growth And Weaker Earnings

Groupe Bruxelles Lambert (ENXTBR:GBLB) has released first quarter 2026 results, reporting sales of €1,631.5 million and net income of €64.6 million, giving investors fresh data on profitability trends. See our latest analysis for Groupe Bruxelles Lambert. The latest results come after a softer patch in the share price, with a 30 day share price return of down 5.46% and a 90 day share price return of down 6.98%. However, the 1 year total shareholder return of 12.57% and 3 year total shareholder return of 13.93% point to steadier progress when dividends are included. If this earnings update has you thinking about portfolio balance, it could be a good moment to broaden your search with 98 top founder-led companies With sales up year on year but net income and earnings per share lower, and the share price easing in recent months, should investors see Groupe Bruxelles Lambert as undervalued today, or has the market already priced in future growth? Preferred Price-to-Sales of 1.5x: Is it justified? On a P/S multiple, Groupe Bruxelles Lambert looks inexpensive, with the stock trading at 1.5x sales while peers and the wider industry sit much higher. The P/S ratio compares the company’s market value to its revenue, which can be useful when earnings are negative or volatile, as is currently the case here. For Groupe Bruxelles Lambert, the current P/S of 1.5x is described as good value compared both to its peer average of 22.6x and to the European Diversified Financial industry average of 2x. This suggests the market is pricing its revenue stream at a discount. That gap to both peers and the sector is wide. If sentiment or profitability shifts, the multiple could move closer to where comparable companies trade over time. See what the numbers say about this price — find out in our valuation breakdown. Result: Price-to-Sales of 1.5x (UNDERVALUED) However, you still need to weigh risks such as the recent share price weakness and the current net income loss of €362.0 million against that low P/S ratio. Find out about the key risks to this Groupe Bruxelles Lambert narrative. Next Steps With mixed signals on valuation and profitability, this is the moment to look closely at the underlying data yourself and move quickly if needed. To see the balance of concerns and potential upside in one place, review the 1 key reward and 1 important warning sign Looking for more investment ideas? If you stop with just one stock, you risk missing other opportunities that might fit your goals even better, so keep your options open and compare across ideas. Spot potential bargains early by reviewing screener containing 541 high quality undiscovered gems that combine solid fundamentals with limited market attention. Strengthen your portfolio’s foundation by scanning solid balance sheet and fundamentals stocks screener (389 results) to see companies with healthier finances. Reduce potential volatility by checking 306 resilient stocks with low risk scores that score well on resilience metrics. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for Free